vs
Side-by-side financial comparison of Edwards Lifesciences (EW) and NEW JERSEY RESOURCES CORP (NJR). Click either name above to swap in a different company.
Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $939.4M, roughly 1.8× NEW JERSEY RESOURCES CORP). NEW JERSEY RESOURCES CORP runs the higher net margin — 23.3% vs 23.1%, a 0.2% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs -33.0%). Over the past eight quarters, NEW JERSEY RESOURCES CORP's revenue compounded faster (111.6% CAGR vs 9.7%).
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
New Jersey Resources is an energy services holding company based in Wall Township, New Jersey. It is a Fortune 1000 company, and a member of the Forbes Platinum 400. New Jersey Natural Gas is its principal subsidiary.
EW vs NJR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $939.4M |
| Net Profit | $380.7M | $218.9M |
| Gross Margin | 78.0% | — |
| Operating Margin | 1.8% | 32.0% |
| Net Margin | 23.1% | 23.3% |
| Revenue YoY | 16.7% | -33.0% |
| Net Profit YoY | 6.8% | 7.2% |
| EPS (diluted) | $0.66 | $2.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | $939.4M | ||
| Q4 25 | $1.6B | $440.9M | ||
| Q3 25 | $1.6B | $188.3M | ||
| Q2 25 | $1.5B | $234.8M | ||
| Q1 25 | $1.4B | $569.2M | ||
| Q4 24 | $1.4B | $359.0M | ||
| Q3 24 | $1.4B | $265.7M | ||
| Q2 24 | $1.4B | $209.9M |
| Q1 26 | $380.7M | $218.9M | ||
| Q4 25 | $91.2M | $122.5M | ||
| Q3 25 | $291.1M | $15.1M | ||
| Q2 25 | $333.2M | $-15.1M | ||
| Q1 25 | $358.0M | $204.3M | ||
| Q4 24 | $385.6M | $131.3M | ||
| Q3 24 | $3.1B | $91.1M | ||
| Q2 24 | $366.3M | $-11.6M |
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
| Q1 26 | 1.8% | 32.0% | ||
| Q4 25 | 9.6% | 40.6% | ||
| Q3 25 | 19.8% | 21.5% | ||
| Q2 25 | 26.8% | -0.5% | ||
| Q1 25 | 27.9% | 49.2% | ||
| Q4 24 | 22.6% | 52.8% | ||
| Q3 24 | 25.9% | 55.0% | ||
| Q2 24 | 26.8% | 2.8% |
| Q1 26 | 23.1% | 23.3% | ||
| Q4 25 | 5.8% | 27.8% | ||
| Q3 25 | 18.7% | 8.0% | ||
| Q2 25 | 21.7% | -6.4% | ||
| Q1 25 | 25.3% | 35.9% | ||
| Q4 24 | 27.8% | 36.6% | ||
| Q3 24 | 226.7% | 34.3% | ||
| Q2 24 | 26.7% | -5.5% |
| Q1 26 | $0.66 | $2.16 | ||
| Q4 25 | $0.16 | $1.21 | ||
| Q3 25 | $0.50 | $0.15 | ||
| Q2 25 | $0.56 | $-0.15 | ||
| Q1 25 | $0.61 | $2.02 | ||
| Q4 24 | $0.65 | $1.31 | ||
| Q3 24 | $5.13 | $0.91 | ||
| Q2 24 | $0.61 | $-0.12 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EW
Segment breakdown not available.
NJR
| Utility | $640.9M | 68% |
| Nonutility | $298.5M | 32% |
